Clin2
NCT07068607Likely a fitRecruiting

Comparing two treatments for H. pylori infection

Gastritis, Indigestion, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer

Treatments studied

Part of Cancer, Digestive system clinical trials.

This study tests whether a new stomach acid medicine called vonoprazan, combined with different antibiotics, works better than standard treatments to clear an H. pylori infection. It is for people who have never been treated for H. pylori and want to try a shorter, simpler treatment course.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
400 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old
  • You have tested positive for H. pylori (a stomach infection) and have never been treated for it
  • You are not allergic to any of the study medications (vonoprazan, amoxicillin, tetracycline, metronidazole, or clarithromycin)
  • You have not taken antibiotics or acid-reducing medicines in the past month (except aspirin ≤100 mg/day)
  • You are not pregnant, breastfeeding, or planning pregnancy during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07242456Recruiting· Phase 2/Phase 3
Comparing two treatments for H. pylori infection

This study tests two different combinations of medications to treat H. pylori, a stomach bacteria that can cause ulcers. You would take one of the two combinations for a short time to see which works better at getting rid of the infection.

Hangzhou, Zhejiang
NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka
NCT07624422Not yet recruiting· Phase 4
Helicobacter pylori infection treatment study

This study tests a new antibiotic combination to treat stomach infections caused by H. pylori bacteria. It may help clear the infection and reduce stomach problems.

Damascus
NCT06959368Recruiting· Phase 4
New H. pylori treatment vs standard triple therapy

This trial compares a newer drug (vonoprazan) plus antibiotics to the standard triple therapy for eradicating H. pylori infection in the stomach. It may be a good option if you have stomach symptoms like indigestion, acid reflux, or a non-bleeding ulcer and have not been treated for H. pylori before.

Hyderabad, Telangana
NCT06723197Recruiting· Phase 4
Comparing treatment lengths for H. pylori infection

This trial compares different lengths of treatment with two or four medications to see which works best for clearing H. pylori, a stomach bacteria that can cause ulcers. It is for people who have not been treated for this infection before.

Jinan, Shandong
NCT06349486Recruiting
Comparing new treatments for H. pylori infection

This trial compares three different medication combinations to see which works best for treating H. pylori infection. If you have H. pylori and haven't been treated yet, you may be able to join.

Kaohsiung City

Hear when a new Gastritis, Indigestion, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.